Gapping up
In reaction to earnings/guidance:
- DLO +15.7%, GOOS +13.5%, TTWO +12.8%, BBWI +9.5%, BEKE +6.6%, DOLE +4.6%, CSIQ +4.5%, ZTO +3.9%, EXP +2.4%, BOWL +2%, SNPS +1.9%, WMT +1.4%
Other news:
- EYPT +10.5% (sold YUTIQ (fluocinolone acetonide intravitreal implant) 0.18mg to Alimera Sciences (ALIM))
- SONY +4% (assesses partial spin-off)
- CABA +3.8% (prices offering of 7.25 mln shares of common stock at $12.00 per share)
- ACET +3% (Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting)
- TXG +2.8% (TXG wins injunction in patent litigation with NSTG)
- SNOW +2.2% (in talks to buy search startup Neeva according to The Information)
- UBA +2% (Regency Centers (REG) to acquire Urstadt Biddle Properties in all-stock transaction valued at approximately $1.4 bln)
- FGEN +2% (topline data from Company's Phase 3 clinical study of roxadustat for treatment of anemia in patients receiving concurrent chemotherapy treatment for non-myeloid malignancies in China)
- PLX +1.7% (is eligible to receive a $20 million milestone payment from its commercial partner Chiesi Global Rare Diseases)
Analyst comments:
- ALB +2% (upgraded to Buy from Neutral at UBS)
- DT +1.8% (upgraded to Buy from Neutral at BTIG Research)
ok